Prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)

Details

Files
Project Status:
Active
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HC0060-000

Implementation Advice

Stakeholder Input Deadline

June 8, 2023

Draft Report Posted (Target)

July 23, 2023

Stakeholder Feedback Deadline

August 3, 2023

Final Report Posted (Target)

August 30, 2023

Call for feedback
Call for feedback:
Feedback Due By
Feedback Due By:
Consultation document
Consultation document: Proposed Project Scope
Product Line
Product Line: Health Technology Review
Project Number
Project Number: HC0060-000